Kaiser Permanente’s 2-1-1 pre-exposure prophylaxis (PrEP) program shows event-driven dosing works.
The findings add to evidence that injectable PrEP could ultimately have greater real-world efficacy than daily oral PrEP in many populations, thanks to better adherence.
New findings from the Antibody-Mediated Prevention (AMP) studies indicate that broadly neutralizing antibodies can work, but several will need to be used in combination.
A new expert consensus statement explores how providers can give birthing parents who are living with HIV the information they need to decide for themselves.
Developing a vaccine for HIV presents more challenges than creating one for COVID-19, but research that has led to the new COVID vaccines can help bring an HIV vaccine closer to reality.
‘PrEP for Women Too’ Campaign Aims to Bring This Empowering HIV Prevention Tool to More Black and Latinx Women
Despite PrEP being safe to take for people of all genders, there’s still a lag in uptake among cisgender women.
Sex is a vital part of human life—and clinicians should be asking about it.
Open conversations between care providers and Black women are vitally important in order to empower women with information about HIV and how to protect their health.
Washington, D.C. area community organizations and clinics have moved a lot of prevention efforts online, but much is missing without in-person contact.
A Vaginal Ring to Prevent HIV Was Given a Positive Opinion by a European Drug Regulator. Here’s What You Need to Know About It.
Two experts discuss the history of the ring, how it works, and when it may come to the United States.
To Increase Access to HIV Post-Exposure Prophylaxis, New York State Updated Its Guidelines for Clinicians
If you’re a provider in or outside the state, you’ll want to read these new guidelines.